Stock Market Today

Stock Market Today: S&P 500, Nasdaq Hit Record Highs on Pfizer Vaccine Approval

The Pfizer-BioNTech COVID-19 vaccine became the first to earn full FDA approval Monday, igniting a broad rally in stocks.

The bulls came out Monday as the nation's fight against COVID-19 took a significant step.

The U.S. Food and Drug Administration today gave its full approval to the COVID-19 vaccine manufactured by Pfizer (PFE, +2.5%) and Germany's BioNTech (BNTX, +9.6%), making it the first shot to receive the designation. More than 200 million doses of the drug, which will now be marketed as Comirnaty, have already been administered under the FDA's emergency-use authorization.

"Considering the recent spike in cases and some of the disappointing economic data, this is another step in the right direction," says Ryan Detrick, chief market strategist for LPL Financial, "and it helps give confidence to those who might still be holding out on getting the vaccine."

"To the extent that the general public becomes more comfortable living with the virus – either because of increased vaccinations or natural immunity from recovered infections – the economy is likely to continue on its upward trajectory," says Chris Zaccarelli, chief investment officer for Independent Advisor Alliance. "The economic recovery is what is driving corporate earnings and the stock market to all-time highs, and we expect that to continue through 2021 and into 2022."

The energy sector (+3.8%) led the way, as U.S. crude oil futures snapped a seven-day losing streak with a 5.6% jump to $65.64 per barrel.

Sign up for Kiplinger's FREE Investing Weekly e-letter for stock, ETF and mutual fund recommendations, and other investing advice.

The Nasdaq Composite soared 1.6% higher to a record close of 14,942, putting it within reach of the nice, round 15,000 level. The S&P 500 also notched a record high, gaining 0.9% to 4,479. And the Dow Jones Industrial Average closed up 0.6% to 35,335.

Other news in the stock market today:

  • The small-cap Russell 2000 advanced 1.9% to 2,208.
  • Robinhood (HOOD, +6.2%) was a notable mover on Wall Street today after a number of analysts weighed in on the investing platform. Among them was Mizuho Securities analyst Dan Dolev, who initiated coverage with a Buy rating and a $68 price target. "With its 22.5 million active users and fetching 50% of all new retail U.S. accounts, we view Robinhood not as a meme stock phenomenon, but as a singularity that captures Generation Z's zeitgeist," Dolev says.
  • Shares of Tesla (TSLA, +3.8%) also moved higher on the back of some analyst attention. In the wake of TSLA's artificial intelligence (AI) day last week, Deutsche Bank analyst Emmanuel Rosner reiterated his Buy rating on the electric vehicle (EV) maker. "We came away with greater appreciation for Tesla’s efforts in AI," Rosner says. "Tesla outlined a very ambitious effort to develop a high performance neural network with very scalable underlying compute and accurate+fast data labeling." Rosner believes this platform "could be sold 'as a service' to other machine learning (ML) use cases."
  • Gold futures jumped 1.3% to settle at $1,806.30 an ounce as the U.S. dollar cooled.
  • The CBOE Volatility Index (VIX) declined 7.9% to 17.09.
  • Earlier this morning, Bitcoin prices eclipsed $50,000 for the first time since May. They retreated a bit to $49,297.32 by the afternoon, up 1.3% from Friday. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.) 
stock chart for 082321

Getty Images

Vaccine Winners and Losers

As energy demonstrated, some sectors are more warmly greeting Monday's FDA decision than others.

Chris Zaccarelli, chief investment officer for Independent Advisor Alliance, notes that defensive sectors such as utilities (-1.3%) and consumer staples (-0.3%) are likely to underperform if the market's reopening trade continues; on Monday, at least, that was the case.

So what looks appealing? Consumer discretionary stocks (and retail companies in particular) are "likely to benefit from this announcement because increased consumer confidence as a result of additional vaccinations should lead to higher sales at those companies," he says. Indeed, discretionaries (+1.3%) were one of the session's best sectors.

Looking outside any one particular area of the market, our 21 best stocks to buy for the rest of 2021 were largely selected for their ability to benefit from continued rejuvenation in the U.S. economy. That's based on ongoing progress against the virus, sure – but also on spending elsewhere in the economy, be it a Washington plan for infrastructure, or corporate America upgrading its technological tools.

Kyle Woodley was long TSLA as of this writing.

Most Popular

Your Guide to Roth Conversions
Special Report
Tax Breaks

Your Guide to Roth Conversions

A Kiplinger Special Report
February 25, 2021
The 12 Best Tech Stocks to Buy for 2022
tech stocks

The 12 Best Tech Stocks to Buy for 2022

The best tech-sector picks for the year to come include plays on some of the most exciting emergent technologies, as well as several old-guard mega-ca…
January 3, 2022
How to Know When You Can Retire
retirement

How to Know When You Can Retire

You’ve scrimped and saved, but are you really ready to retire? Here are some helpful calculations that could help you decide whether you can actually …
January 5, 2022

Recommended

8 Facts You Need to Know About Stock Market Corrections
Markets

8 Facts You Need to Know About Stock Market Corrections

Scary as they are, drawdowns are a normal part of the investing process. Having a financial plan in place and sticking to it is every investor's best …
January 23, 2022
Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020
Stock Market Today

Stock Market Today (1/21/22): Nasdaq Sinks Again, Ends Worst Week Since 2020

A negative earnings reaction for Netflix (NFLX) and options expiration sparked a volatile session for stocks.
January 21, 2022
Kiplinger's Weekly Earnings Calendar
stocks

Kiplinger's Weekly Earnings Calendar

Check out our earnings calendar for the upcoming week, as well as our previews of the more noteworthy reports.
January 21, 2022
Stock Market Today (1/20/22): Foiled Again! Sizable Snap-Back Fizzles Late
Stock Market Today

Stock Market Today (1/20/22): Foiled Again! Sizable Snap-Back Fizzles Late

The Nasdaq fell even further into correction territory Thursday after early gains collapsed in the afternoon.
January 20, 2022